Mirum Pharmaceuticals, Inc.
MIRMNASDAQ
Healthcare
Biotechnology
$94.24
-0.38(-0.4%)
52W $38.39 – $108.62
Quick:
SCHEDULE 13G/A
Mar 27, 2026 (1 weeks ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Feb 25, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Feb 25, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 13, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Jan 27, 2026 (2 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Jan 26, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 12, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 19, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 19, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 8, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Dec 5, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 17, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Nov 4, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 4, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Nov 4, 2025 (5 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13D/A
Aug 20, 2025 (7 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active